HOWSON TAMAR D 4
4 · Cue Biopharma, Inc. · Filed Sep 18, 2020
Insider Transaction Report
Form 4
HOWSON TAMAR D
Director
Transactions
- Award
Stock Option (right to buy)
2020-09-17+50,000→ 50,000 totalExercise: $17.21Exp: 2030-09-17→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning March 17, 2021.